Early research (Phase 1)Ended earlyNCT03922477
What this trial is testing
A Study Evaluating the Safety and Pharmacokinetics of Atezolizumab Administered in Combination With Hu5F9-G4 to Patients With Relapsed and/or Refractory Acute Myeloid Leukemia
Who this might be right for
Acute Myeloid Leukemia
Hoffmann-La Roche 13